Bioorganic & Medicinal Chemistry Letters
Volume 15, Issue 4, 15 February 2005, Pages 977-982
and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane
Shrenik K. Shaha, , , Natalie Chena, Ravindra N. Guthikondaa, Sander G. Millsa, Lorraine Malkowitzb, Martin S. Springerb, Sandra L.
- DOI:
http://dx.doi.org/doi:10.1016/j.bmcl.2004.12.044